Meyka AI API is live for developers.Start building.
Advertisement
BB Biotech AG

BB Biotech AG (BBAGF) Stock Overview

Explore BB Biotech AG’s financial performance, market position, analyst ratings, and future outlook.

BBAGF●PNK
Financial ServicesAsset Management
$54.67
$6.88(11.18%)
U.S. Market opens in 8h 0m
Advertisement

BB Biotech AG (BBAGF)

Meyka AI Score

Z

Key Financials

Market Cap4.2B
P/E Ratio12.56
EPS (TTM)$-17.29
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$57.72

BBAGF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BB Biotech AG (BBAGF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 100.00, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $57.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.56 and a market capitalization of 4.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-28.12%
1-Month Change
-28.12%
3-Month Change
-28.12%
6-Month Change
-11.18%
Year-to-Date (YTD) Change
-11.18%
1-Year Change
-0.47%
3-Year Change
-28.12%
5-Year Change
-28.12%
All-Time (Max) Change
-79.66%

Contact Information

https://www.bbbiotech.ch/en/bb-biotech
41 44 267 67 00
Seestrasse 16, Kusnacht, NaN, 8700

Company Facts

100 Employees
IPO DateOct 12, 2015
CountryCH

Frequently Asked Questions